期刊文献+

肾癌术后应用α-干扰素的疗效分析 被引量:6

α-Interferon in the Treatment of Renal Cell Carcinoma after Surgical Management
暂未订购
导出
摘要 目的:探讨肾癌术后应用α-干扰素的治疗效果。方法:82例肾癌患者随机分成两组:治疗组45例。肾癌术后行α-干扰素治疗,对照组37例单纯行手术治疗。结果:两组早期(Robson分期Ⅰ~Ⅱ期)。肾癌患者5年生存率尤显著性差异;晚期(Ⅲ期)。肾癌患者5年生存率治疗组明显高于对照组(P〈0.05)。结论:晚期(Ⅲ期)肾癌患者肾癌术后应用α-干扰素治疗能提高生存率。 Objective: To determine the effect of α- interferon in the treatment of renal cell carcinoma after nephrectomy. Methods: A total of 82 cases of renal cell carcinoma were reviewed and divided into two groups: the therapeutic: group treated by α- interferon after nephrectomy and the control group with nepthrectomy alone. Results: The 5 - year survival rate among the two groups in stage Ⅰ~Ⅱ renal carcinoma was similar, but there was significant difference in 5 - year survival rate among two groups in advanced renal carcinoma. Conclusions: α- interferon was effective for advanced renal carcinoma.
出处 《华西医学》 CAS 2006年第2期288-289,共2页 West China Medical Journal
关键词 Α-干扰素 肾肿瘤 肾癌根治术 α-interferon kidney neoplasrns radical nephrectomy
  • 相关文献

参考文献4

  • 1Papac R J,Keohane M F.Hormonal therapy for metastatic renal cell carcinoma combined androgen and provera followed by high dose tamoxifen[J].Eur J Cancer,1993,29A:997-999.
  • 2Lummen G,Goepel M,Mollhoff S,et al.Phase Ⅱ study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma[J].J Urol,1996,155:455-458.
  • 3Horoszewics JS,Murphy GP.An assessment of the current use of human intertferons in therapy of urological cancers[J].J Urol,1989,142:173-1181.
  • 4Atzpodien J,Kirchner H.IL-2 in combination with IFN-alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma long-term results of a controlled randomized clinical trial[J].Br J Cancer,2001,85:1130-1136.

同被引文献97

  • 1张建国,王艳丽,李静,孙宗立,周四维.生物治疗预防肾癌根治术后复发和转移的远期疗效观察[J].中国医师杂志,2005,7(10):1309-1311. 被引量:7
  • 2钟华,顾方六.肾癌生物治疗的现状和前景[J].中华泌尿外科杂志,1996,17(9):560-563. 被引量:10
  • 3张军杰,刘中生,刘行峰.肾癌根治术后免疫治疗的疗效观察[J].河南外科学杂志,2006,12(3):42-43. 被引量:3
  • 4谭万龙,谢毅,吴元东,朱文辉,郑少斌.腺病毒介导融合双自杀基因治疗膀胱癌[J].南方医科大学学报,2006,26(5):594-597. 被引量:13
  • 5李爱军,孙颖浩,杨波,王林辉.450例肾细胞癌的临床回顾分析[J].临床泌尿外科杂志,2006,21(12):907-909. 被引量:11
  • 6Pizzocaro G,Piva L,Colavita M,Ferri S,Artusi R,Boracchi P,et a1.Interferon adjuvant to radical nephrectomy in robson stages Ⅱ and Ⅲ renal cell carcinoma:a multicentric randomized study[J].Journal of Clinical Oncology,2001,19:425-431.
  • 7Pavone L,Andrulli S,Santi R,Majori M,Buzio C.Long term treatment with low doses of interleukin-2 and interferon alpha:immunological effects in advanced renal cell cancer[J].Cancer Immunol Immunother,2001,50:82-86.
  • 8Hong S K,Kwak C,Lee S E.Adjuvant interleukin-2,interferon-alpha,and 5-fluorouracil immunochemotherapy after radical nephrectomy for locally advanced renal cell carcinoma[J].Urology,2005,66:518-522.
  • 9Olencki T,Peereboom D,Wood L,Budd G T,Novick A,Finke J,et al.Phase Ⅰ and Ⅱ trials of subcutaneously administered rIL-2,interferon alpha-2a,and fluorouracil in patients with memstatic renal carcinoma[J].Cancer Res Clin Oncol,2001,127:319-324.
  • 10Kankuri M,Pelliniemi T T,Pyrhnen S,Nikkanen V,Helenius H,Salminen E.Feasibility of prolonged use of interferon-α in metastatic kidney caroinoma:a phase Ⅱ study[J].Cancer,2001,92:761-767.

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部